Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $4.09 Million - $4.67 Million
-18,224 Reduced 18.8%
78,698 $19.7 Million
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $22.6 Million - $25.7 Million
96,922 New
96,922 $24 Million
Q3 2022

Nov 10, 2022

SELL
$247.06 - $1507.4 $24.6 Million - $150 Million
-99,717 Reduced 66.39%
50,492 $13 Million
Q2 2022

Aug 19, 2022

BUY
$237.11 - $299.66 $17.9 Million - $22.6 Million
75,572 Added 101.25%
150,209 $38.1 Million
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $7.11 Million - $8.73 Million
-27,648 Reduced 27.03%
74,637 $21.9 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $23 Million - $25.9 Million
78,776 Added 335.09%
102,285 $33.7 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $6.4 Million - $7.82 Million
23,509 New
23,509 $7.16 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $8.14 Million - $9.83 Million
-36,174 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $4.39 Million - $5.08 Million
-20,659 Reduced 36.35%
36,174 $8.14 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $1.79 Million - $2.07 Million
8,438 Added 17.44%
56,833 $12.6 Million
Q3 2020

Nov 16, 2020

BUY
$177.16 - $215.33 $8.57 Million - $10.4 Million
48,395 New
48,395 $10.4 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $3.02 Million - $4.15 Million
-23,479 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $1.54 Million - $2.15 Million
-12,709 Reduced 35.12%
23,479 $3.25 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $4.83 Million - $5.55 Million
36,188 New
36,188 $5.55 Million
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $397,263 - $429,742
-2,934 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $366,397 - $421,703
2,934 New
2,934 $419,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.